The INFECIR-2 Albumin Prevention Study

Clinical trial NCT02034279 · TERMINATED

Trial details

NCT number: NCT02034279
Sponsor: EASL - CLIF Consortium
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Advanced Chronic Liver Disease Urinary Infection Pneumonia Cholangitis Other Bacterial Diseases

Start date: 2014-05-01
Primary completion: 2016-12-31
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.